173 related articles for article (PubMed ID: 2742865)
41. Pharmacological properties of R-755, a novel acyl-CoA:cholesterol acyltransferase inhibitor, in cholesterol-fed rats, hamsters and rabbits.
Matsui Y; Horiuchi K; Yamamoto K; Kanai K
Jpn J Pharmacol; 2001 Apr; 85(4):423-33. PubMed ID: 11388647
[TBL] [Abstract][Full Text] [Related]
42. Mechanism of the inhibition of cholesterol absorption by DL-melinamide: inhibition of cholesterol esterification.
Natori K; Okazaki Y; Nakajima T; Hirohashi T; Aono S
Jpn J Pharmacol; 1986 Dec; 42(4):517-23. PubMed ID: 3807053
[TBL] [Abstract][Full Text] [Related]
43. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
[TBL] [Abstract][Full Text] [Related]
44. Homeostatic restoration of microsomal lipids and enzyme changes in HMG-CoA reductase and acyl-CoA: cholesterol acyltransferase in chick liver.
Garcia-Gonzalez M; Segovia JL; Alejandre MJ
Mol Cell Biochem; 1992 Oct; 115(2):173-8. PubMed ID: 1448062
[TBL] [Abstract][Full Text] [Related]
45. Effect of dietary cholesterol and cholestyramine on developmental pattern of 3-hydroxy-3-methylglutaryl-CoA reductase.
Alejandre MJ; Ramirez H; Segovia JL; Garcia-Peregrin E
Ann Nutr Metab; 1985; 29(2):111-8. PubMed ID: 3994297
[TBL] [Abstract][Full Text] [Related]
46. Antihypercholesterolemic property of naringin alters plasma and tissue lipids, cholesterol-regulating enzymes, fecal sterol and tissue morphology in rabbits.
Jeon SM; Park YB; Choi MS
Clin Nutr; 2004 Oct; 23(5):1025-34. PubMed ID: 15380892
[TBL] [Abstract][Full Text] [Related]
47. Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin.
Chao Y; Chen JS; Hunt VM; Kuron GW; Karkas JD; Liou R; Alberts AW
Eur J Clin Pharmacol; 1991; 40 Suppl 1():S11-4. PubMed ID: 2044637
[TBL] [Abstract][Full Text] [Related]
48. Cholesterol absorption in rat intestine: role of cholesterol esterase and acyl coenzyme A:cholesterol acyltransferase.
Gallo LL; Clark SB; Myers S; Vahouny GV
J Lipid Res; 1984 Jun; 25(6):604-12. PubMed ID: 6747463
[TBL] [Abstract][Full Text] [Related]
49. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
[TBL] [Abstract][Full Text] [Related]
50. Effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits and cholesterol-fed rabbits.
Wajima T; Makita S; Oshima K
Pharmacology; 2004 Mar; 70(3):123-9. PubMed ID: 14752232
[TBL] [Abstract][Full Text] [Related]
51. Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative.
Slater EE; MacDonald JS
Drugs; 1988; 36 Suppl 3():72-82. PubMed ID: 3076125
[TBL] [Abstract][Full Text] [Related]
52. Activity of acyl-CoA: cholesterol acyltransferase and 3-hydroxy-3-methylglutaryl-CoA reductase in subfractions of hepatic microsomes enriched with cholesterol.
Hashimoto S; Drevon CA; Weinstein DB; Bernett JS; Dayton S; Steinberg D
Biochim Biophys Acta; 1983 Nov; 754(2):126-33. PubMed ID: 6197090
[TBL] [Abstract][Full Text] [Related]
53. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
54. Hypercholesterolaemia: simvastatin and pravastatin alter cholesterol metabolism by different mechanisms.
Owens D; Collins P; Johnson A; Tighe O; Robinson K; Tomkin GH
Biochim Biophys Acta; 1991 Apr; 1082(3):303-9. PubMed ID: 1903069
[TBL] [Abstract][Full Text] [Related]
55. Different effect of simvastatin and atorvastatin on key enzymes involved in VLDL synthesis and catabolism in high fat/cholesterol fed rabbits.
Verd JC; Peris C; Alegret M; Díaz C; Hernández G; Vázquez M; Adzet T; Laguna JC; Sánchez RM
Br J Pharmacol; 1999 Jul; 127(6):1479-85. PubMed ID: 10455299
[TBL] [Abstract][Full Text] [Related]
56. The role of age on the cholesterol-metabolizing enzymes and lipid levels in chick plasma and liver microsomes after cholesterol enriched diet cessation.
Segovia JL; García-González M; Alejandre MJ
Biochem Mol Biol Int; 1994 Aug; 34(1):93-100. PubMed ID: 7849630
[TBL] [Abstract][Full Text] [Related]
57. Increase in serum and bile cholesterol and HMG-CoA reductase by lovastatin in rats.
Yamauchi S; Linscheer WG; Beach DH
Am J Physiol; 1991 Apr; 260(4 Pt 1):G625-30. PubMed ID: 2018137
[TBL] [Abstract][Full Text] [Related]
58. Effect of catecholamines on the hepatic rate-limiting enzymes of cholesterol metabolism in normally fed and cholesterol-fed rabbits.
Deverey R; O'Donnell L; Tomkin GH
Biochim Biophys Acta; 1986 Jul; 887(2):173-81. PubMed ID: 3719008
[TBL] [Abstract][Full Text] [Related]
59. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
[TBL] [Abstract][Full Text] [Related]
60. Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
Desager JP; Horsmans Y
Clin Pharmacokinet; 1996 Nov; 31(5):348-71. PubMed ID: 9118584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
